Cross-generational comparison of dispensed pharmacotherapy for depression

International Journal of Health Care Quality Assurance

Volumn 22, Issue 3, 2009, Pages 300-312

  Sewitch, Maida J ^a   Bexton, Brian ^b   Rahme, Elham ^a   Galarneau, Sophie ^b   Blais, Régis ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Depression; Drug controls; Drugs; Gender

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; DEPRESSION; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CHILD; COHORT STUDIES; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 67649769098     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526860910953566     Document Type: Article

References (64)

1. AACAP (1998), Practice parameters for the assessment and treatment of children and adolescents with depressive disorders, Journal of the American Academy of Child Adolescent Psychiatry, Vol. 37 No. 10S Supplement, pp. 63S-83S.
2. Adler, D. (2000), Improving the quality of depression treatment in primary care, Medical Outcomes Trust Monitor, Vol. 5 No. 1, pp. 3-5.
3. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders. DSM-IV, 4th ed., American Psychiatric Association, Washington, DC.
4. American Psychiatric Association (2000), Practice guidelines for the treatment of patients with major depressive disorder (revised), American Journal of Psychiatry, Vol. 1574 No. 4, pp. 1-45.
5. Angst, J., Angst, F. and Gerber-Weder, R.G.A. (2005), Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up, Archives of Suicide Research, Vol. 9 No. 3, pp. 279-300.
6. Appleby, L., Shaw, J., Amos, T., McDonnell, R., Harris, C., McCann, K., Kiernan, K., Davies, S., Bickley, H. and Parsons, R. (1999), Suicide within 12 months of contact with mental health services: national clinical survey, British Medical Journal, No. 318, pp. 1235-9.
7. Beaudet, M.P. (2000), Psychological health-depression, Health Reports, Vol. 11 No. 3, pp. 63-75.
8. Benton, T., Saab, J. and Evans, D.L. (2007), Medical co-morbidity in depressive disorders, Annals of Clinical Psychiatry, Vol. 19 No. 4, pp. 289-303.
9. Broadhead, W.E., Blazer, D.G., George, L.K. and Tse, C.K. (1990), Depression, disability days, and days lost from work in a prospective epidemiologic survey, JAMA, Vol. 264 No. 19, pp. 2524-8.
10. Canadian Network for Mood and Anxiety Treatments (CANMAT) (1999), Guidelines for the Diagnosis and Pharmacological Treatment of Depression, 1st ed., CANMAT, Toronto, pp. 1-76.
11. Crystal, S., Sambamoorthi, U., Walkup, J.T. and Akincigil, A. (2003), Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends, Journal of the American Geriatrics Society;, Vol. 51 No. 12, pp. 1718-28.
12. DeBar, L.L., Clarke, G.N., O'Connor, E. and Nichols, G.A. (2001), Treated prevalence, incidence, and pharmacotherapy of child and adolescent mood disorders in an HMO, Mental Health Services Research, Vol. 3 No. 2, pp. 73-89.
13. Demers, M. (1995), Frequent users of ambulatory health care in Quebec: the case of doctor-shoppers, Canadian Medical Association Journal, Vol. 153 No. 1, pp. 37-42.
14. Eisenberg, L. (1992), Treating depression and anxiety in primary care: closing the gap between knowledge and practice, New England Journal of Medicine, Vol. 326 No. 16, pp. 1080-4.
15. Ensinck, K.T.J.L., Schuurman, A.G., van den Akker, M., Metsemakers, J.F.M., Kester, A.D.M., Knottnerus, J.A. and Buntinx, F. (2002), Is there an increased risk of dying after depression?, American Journal of Epidemiology, Vol. 156 No. 11, pp. 1043-8.
16. Fairman, K.A., Drevets, W.C., Kreisman, J.J. and Teitelbaum, F. (1998), Course of antidepressant treatment, drug type, and prescriber's specialty, Psychiatric Services, Vol. 49 No. 9, pp. 1180-6.
17. Glied, S. and Pine, D.S. (2002), Consequences and correlates of adolescent depression, Archives of Pediatric & Adolescent Medicines, Vol. 156, October, pp. 1009-14.
18. Gorman, J.M. (2006), Gender differences in depression and response to psychotropic medication, Gender Medicine, Vol. 3 No. 2, pp. 93-109.
19. Harris, E.C. and Barraclough, B. (1997), Suicide as an outcome for mental disorders: a meta-analysis, British Journal of Psychiatry, Vol. 170 No. 3, pp. 205-28.
20. Havik, O.E., Sivertsen, B., Relbo, A., Hellesvik, M., Grov, I., Geiran, O., Andreassen, A.K., Sinonsen, S. and Gullestad, L. (2007), Depressive symptoms and all-cause mortality after heart transplantation, Transplantation, Vol. 84 No. 1, pp. 97-103.
21. Howland, R.H. (1993), General health, health care utilization, and medical comorbidity in dysthymia, International Journal of Psychiatry in Medicine, Vol. 23 No. 3, pp. 211-38.
22. Johnson, J., Weissman, M.M. and Klerman, G.L. (1992), Service utilization and social morbidity associated with depressive symptoms in the community, JAMA, Vol. 267 No. 11, pp. 1478-83.
23. Judd, L.L., Akiskal, H.S., Zeller, P.J., Paulus, M., Leon, A.C., Maser, J.D., Endicott, J., Coryell, W., Kunavac, J.L., Mueller, T.I., Rice, J.P. and Keller, M.B. (2000), Psychosocial disability during the long-term course ofunipolar major depressive disorder, Archives of General Psychiatry, Vol. 57, April, pp. 375-80.
24. Katon, W., Von Korff, M., Lin, E., Lipscomb, P., Russo, J., Wagner, E. and Polk, E. (1990), Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs, General Hospital Psychiatry, Vol. 12 No. 6, pp. 355-62.
25. Katz, S.J., Kessler, R.C., Lin, E. and Wells, K.B. (1998), Medication management of depression in the United States and Ontario, Journal of General Internal Medicine, Vol. 13 No. 2, pp. 77-85.
26. Kessler, R.C. and Frank, R.G. (1997), The impact of psychiatric disorders on work loss days, Psychological Medicine, Vol. 27 No. 4, pp. 861-73.
27. Kessler, R.C., Barber, C., Birnbaum, H.G., Frank, R.G., Greenberg, P.E., Rose, R.M., Simon, G.E. and Wang, P. (1999), Depression in the workplace: effects on short-term disability. Could treating workers' depression help employers to save money on disability? These results are encouraging, Health Affairs, September/October, pp. 163-71.
28. Lett, H.S., Blumenthal, J.A., Babyak, M.A., Catellier, D.J., Carney, R.M., Berkman, L.F., Burg, M.M., Mitchell, P., Jaffe, A.S. and Schneiderman, N. (2007), Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction, Health Psychology, Vol. 26 No. 4, pp. 418-27.
29. Lewinsohn, P.M., Rohde, P. and Seeley, J.R. (1998), Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications, Clinical Psychology Review, Vol. 18 No. 7, pp. 765-94.
30. Lewinsohn, P.M., Rohde, P., Klein, D.N. and Seeley, J.R. (1999), Natural course of adolescent major depressive disorder: I. Continuity into young adulthood, Journal of the American Academy of Child Adolescent Psychiatry, Vol. 38 No. 1, pp. 56-63.
31. Lewinsohn, P.M., Rohde, P., Seeley, J.R., Klein, D.N. and Gotlib, I.H. (2000), Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults, American Journal of Psychiatry, Vol. 157 No. 10, pp. 1584-91.
32. Liang, K-Y. and Zeger, S.L. (1986), Longitudinal data analysis using generalized linear models, Biometrika, Vol. 73 No. 1, pp. 13-22.
33. Lin, E.H., Katon, W.J., Simon, G.E., Von Korff, M., Bush, T., Walker, E.A., Unützer, J. and Ludman, E. (2000), Low-intensity treatment of depression in primary care: is it problematic, General Hospital Psychiatry, Vol. 22 No. 2, pp. 78-83.
34. Markowitz, J.C., Kocsis, J.H., Bleiberg, K.L., Christos, P.J. and Sacks, M. (2005), A comparative trial of psychotherapy and pharmacotherapy for 'pure' dysthymic patients, Jopurnal of Affective Disorders, Vol. 89 Nos 1-3, pp. 167-75.
35. Martin, A. and Cohen, D.J. (2000), Adolescent depression: window of (missed?) opportunity, American Journal of Psychiatry, Vol. 157 No. 10, pp. 1549-51.
36. Moride, Y., Galbaud Du Fort, G., Monette, J., Ducruet, T., Boivin, J.-F., Champoux, N. and Crott, R. (2002), Sub-optimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics, Journal of the American Geriatrics Society, Vol. 50 No. 8, pp. 1365-71.
37. Parikh, S.V., Lam, R.W. and the CANMAT Depression Work Group (2001), Clinical guidelines for the treatment of depressive disorders. I. Definitions, prevalence, and health burden, Canadian Journal of Psychiatry, Vol. 46, Suppl. 1, pp. 13S-20S.
38. Parikh, S.V., Lesage, A.D., Kennedy, S.H. and Goering, P.N. (1999), Depression in Ontario: under-treatment and factors related to antidepressant use, Journal of Affective Disorders, Vol. 52 No. 1, pp. 67-76.
39. Parker, G. and Roy, K. (2000), Adolescent depression: a review, Australian and New Zealand, Journal of Psychiatry, Vol. 35 No. 5, pp. 572-80.
40. Percudani, M., Barbui, C., Fortino, I. and Petrovich, L. (2005), Antidepressant drug prescribing among elderly subjects: a population-based study, International Journal of Geriatric Psychiatry, Vol. 20 No. 2, pp. 113-8.
41. Pine, D.S., Cohen, E., Cohen, P. and Brook, J. (1999), Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder, American Journal of Psychiatry, Vol. 156 No. 11, pp. 133-5.
42. RAMQ (2008), The public plan, available at: www.ramq.gouv.qc.ca/en/citoyens/assurancemedicaments/regimepublic/pourqui_enfants.shtml (accessed May 14, 2008).
43. Reinherz, H.Z., Paradis, A.D., Giaconia, R.M., Stashwick, C.K. and Fitzmaurice, G. (2003), Childhood and adolescent predictors of major depression in the transition to adulthood, American Journal of Psychiatry;, Vol. 160 No. 12, pp. 2141-7.
44. Rojas-Fernandez, C., Thomas, V.S., Carver, D. and Tonks, R. (1999), Suboptimal use of antidepressants n the elderly: a population-based study in Nova Scotia, Clinical Therapeutics, Vol. 21 No. 11, pp. 1937-50.
45. SAS Institute (1996), The GENMOD procedure, SAS/STAT Software: Changes and Enhancements for Release 6.12, SAS Institute, Cary, NC, pp. 23-42.
46. SAS Institute (2004), SAS Version 9.1, SAS Institute, Cary, NC.
47. Scheibe, S., Preuschhof, C., Cristi, C. and Bagby, R.M. (2003), Are there gender differences in major depression and its response to antidepressants?, Journal of Affective Disorders, Vol. 75 No. 3, pp. 223-35.
48. Schulberg, H.C., Block, M.R., Madonia, M.J., Scott, C.P., Rodriguez, E., Imber, S.D., Perel, J., Lave, J., Houck, P.R. and Coulehan, J.L. (1996), Treating major depression in primary care practice: eight-month clinical outcomes, Archives of General Psychiatry, Vol. 53 No. 10, pp. 913-9.
49. Sewitch, M.J., Blais, R., Rahme, E., Bexton, B. and Galarneau, S. (2005), Pharmacologic response to adolescents diagnosed with depressive disorders, Psychiatric Services, Vol. 56 No. 9, pp. 1089-97.
50. Sewitch, M.J., Blais, R., Rahme, E., Bexton, B. and Galarneau, S. (2007), Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use, Canadian Journal of Psychiatry, Vol. 52 No. 3, pp. 191-200.
51. Sewitch, M.J., Blais, R., Rahme, E., Galarneau, S. and Bexton, B. (2006), Pharmacologic response to a diagnosis of late-life depression: a population study in Quebec, Canadian Journal of Psychiatry, Vol. 51 No. 6, pp. 363-70.
52. Simantov, E., Schoen, C. and Klein, J.D. (2000), Health-compromising behaviors: why do adolescents smoke or drink? Identifying underlying risk and protective factors, Archives of Pediatric & Adolescent Medicines, Vol. 154 No. 10, pp. 1025-33.
53. Sirey, J., Meyers, B.S., Bruce, M.L., Alexopoulos, G.S. and Perlick, D.A.R.P. (1999), Predictors of antidepressant prescription and early use among depressed outpatients, American Journal of Psychiatry, Vol. 156 No. 5, pp. 690-6.
54. Sood, N., Treglia, M., Obenchain, R.L., Dulisse, B., Melfi, C.A. and Croghan, T.W. (2000), Determinants of antideprssant treatment outcome, American Journal of Managed Care, Vol. 6 No. 12, pp. 1327-36.
55. Stephens, T. and Joubert, N. (2001), The economic burden of mental health problems in Canada, Chronic Diseases in Canada, Vol. 22 No. 1, pp. 18-23.
56. Thorpe, L., Whitney, D.K., Kutcher, S.P., Kennedy, S.H. and the CANMAT Depression Work Group (2001), Clinical guidelines for the treatment of depressive disorders. VI. Special populations, Canadian Journal of Psychiatry, Vol. 46, Suppl. 1, pp. 63S-76S.
57. Unutzer, J. (2002), Diagnosis and treatment of older adults with depression in primary care, Biological Psychiatry, Vol. 52 No. 2, pp. 285-92.
58. Von Korff, M., Wagner, E.H. and Saunders, K. (1992b), A chronic disease score from automated pharmacy data, Journal of Clinical Epidemiology, Vol. 45 No. 2, pp. 197-203.
59. Von Korff, M., Ormel, J., Katon, W. and Lin, E.H.B. (1992a), Disability and depression among high utilizers of health care: a longitudinal analysis, Archives of General Psychiatry, Vol. 49 No. 2, pp. 91-100.
60. Weller, E.B. and Weller, R.A. (2000a), Depression in adolescents growing pains or true morbidity?, Journal of Affective Disorders, Vol. 61, Suppl., pp. S9-S13.
61. Weller, E.B. and Weller, R.A. (2000b), The serious nature of teenage 'blues', Journal of Affective Disorders, Vol. 61, Suppl., p. S1.
62. Wells, K.B., Katon, W., Rogers, B. and Camp, P. (1994), Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study, American Journal of Psychiatry, Vol. 151 No. 5, pp. 694-700.
63. World Health Organization (WHO) (1975), International Classification of Diseases Ninth Revision, WHO, Geneva.
64. Young, A.S., Klap, R., Sherbourne, C.D. and Wells, K.B. (2001), The quality of care for depressive and anxiety disorders in the United States, Archives of General Psychiatry, Vol. 58 No. 1, pp. 55-61.